Emergent Medical Partners, LLP
Venture capitalSan Jose · Seed–Series A · 4 people tracked
Find your way into Emergent Medical Partners, LLP
436 people in our graph share verified history with the Emergent Medical Partners, LLP team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Emergent Medical Partners focuses on early-stage life science entrepreneurs, particularly in the medical device space. The firm positions its value as going 'beyond funding' by bringing combined expertise across the financial, medical, and engineering aspects of medical device development. This blend of capital and domain knowledge is intended to accelerate the path to success for the startups it backs.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 21 of 36 portfolio companiesHealthtech ×15Medical Devices ×12Biotech ×6AI & Machine Learning ×2Circular Economy ×1Consumer ×1Digital Health ×1Enterprise Software ×1
HQs:United States×16Australia×1Canada×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×72 founders×24+ founders×1
Investments · 36 tracked
founders shown can be your intro pathBy year:2020 · 12017 · 12016 · 22012 · 15 dated
EBR Systems develops the WiSE cardiac pacing system, a leadless and physiologic medical device for treating heart failure patients.
HealthtechMedical DevicesSilicon Valley, AU
Parker Willis(Executive Officer)inAllan Will(Executive Chair)inJohn McCutcheon(President, Chief Executive Officer)inMark Cowan(Executive Officer)inStephen O'Conner(Executive Officer)Richard Riley(Executive Officer)
Co-investorsAscension VenturesRunway Growth CapitalMorgenthalerSplit Rock Partners
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.
BiotechHealthtechMedical DevicesLexington, US
HARITH RAJAGOPALAN(Executive Officer, Director)inJAY CAPLAN(Executive Officer, Director)inJay Caplan(Executive Officer, Director)inHarith Rajagopalan(Co-Founder and CEO)inLISA DAVIDSON(Executive Officer)inDiane Marcou(Executive Officer)in
Co-investorsBessemer Venture PartnersCatalio Capital Management, LPMithril Capital ManagementDomain AssociatesGeneral CatalystMITHRIL+2 more
.png)
Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD).
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesRedwood City, US
Christopher K. Zarins(Executive Officer, Director)inCharles A. Taylor(Executive Officer, Director)inNicky Espinosa Hayes(Executive Officer)John Stevens(Executive Officer, Director)inH. Baird Radford, III(Executive Officer)John Farquharin
Co-investorsBain Capital Life SciencesBlue Venture FundsKhosla VenturesLifeforce CapitalLotus CapitalSilver Lake Partners+1 more
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions.
BiotechHealthtechMedical DevicesMountain View, US
Fletcher Wilson(Executive Officer, Director)in
BoardThomas Fogarty(Director)Mel Schatz(Director)
Board seatThomas J. Fogarty· per SEC Form D · $3M raise · filed Jun 2017
Co-investorsLaunchCapitalRiverVest Venture PartnersTreo Ventures, Llc
Arterys provides AI clinical applications for medical imaging that integrate directly into existing PACS and EHR systems to assist physicians with diagnosis and treatment decisions.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Fabien Beckers(Executive Officer, Director)John Axerio-Cilies(Executive Officer, Director)
BoardRobert Brownell(Director)Steve Dow(Director)
Co-investorsAsset Management CompanyKhosla VenturesTemasek
HealthtechRedwood City, US
John B. Simpson(Executive Officer, Director)Himanshu N. Patel(Executive Officer)Mark Weinswig(Executive Officer)Jeffrey M. Soinski(Executive Officer, Director)Matthew Ferguson(Executive Officer)
BoardJames B. McElwee(Director)
Co-investorsLucas Venture Group
HardwareHealthtechMedical DevicesMenlo Park, US
Laura N. Dietch(Executive Officer, Director)Kurt Sparks(Executive Officer)in
BoardSharon Stevenson, DVM, PhD(Director)inDrew Hoffmann(Director)Robert Brownell(Director)Thomas Fogarty, MD(Director)
Co-investorsAzimuth VenturesOkapi Venture Capital
HealthtechHayward, US
GUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)
BoardELIZABETH ROCKETT(Director)WENDE HUTTON(Director)in
Co-investorsFountain Healthcare PartnersKaiser Permanente VenturesMission Bay Capital5AM VenturesCanaan PartnersGE Ventures
Cianna Medical develops oncology products for breast cancer care, including targeted APBI (accelerated partial breast irradiation) therapy and wire-free tumor localization tools for lesions from breast to soft tissue.
BiotechHealthtechMedical DevicesAliso Viejo, US
Gordon H. Busenbark(Executive Officer)Charles Bracken(Executive Officer)inJill Anderson(Executive Officer, Director)in
BoardTom Umbel(Director)Nancy Olson(Director)Tiba Aynechi, Ph.D.(Director)
Co-investorsEmergent Medical PartnersSaints Capital
BiotechPalo Alto, US
William Thomas McClellan(Executive Officer, Director, Promoter)
BoardDonald Ross(Director)Robert Brownell(Director)Cortland Bohacek(Director)
Focal Rx develops bioabsorbable medical devices, specifically the BioZorb 3D Bioabsorbable Marker, for clinical and surgical applications.
HealthtechMedical DevicesAliso Viejo, US
George D Hermann(Executive Officer)inSteven Gex(Executive Officer, Director)Steven Naber(Executive Officer)Gail S Lebovic(Executive Officer, Director)
BoardSharon Stevenson(Director)inRobert Brownell(Director)
Co-investorsOkapi Venture Capital
HeRO Graft is a fully subcutaneous arteriovenous access device for hemodialysis patients with central venous stenosis, designed to reduce infection rates and improve long-term vascular access reliability.
Medical Devices
Co-investorsMutual Capital PartnersAscension VenturesKaiser Permanente Ventures
IT Asset Management Group provides IT asset disposition (ITAD), secure data destruction, and electronics recycling services for retired IT equipment.
Circular EconomyEnterprise Software
Co-investorsTreo Ventures, Llc
HealthtechGlen Burnie, US
Mark Janofsky(Executive Officer)Greg Stokes(Executive Officer)John Spitznagel(Executive Officer, Director)Michael Coppola(Executive Officer)
BoardEran Nadav(Director)Steve Grenfell(Director)
Co-investors1315 Capital
The page describes a custom guitar building business that has suspended custom build orders after purchasing a shop called Guitars Plus, and now sells one-of-a-kind guitars from a location in downtown Victoria.
ConsumerHealthtechVictoria, CA
Jonathan Coe(Executive Officer, Director)
BoardBrant Heise(Director)Eugene Chen(Director)Ferolyn T. Powell(Director)
Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.
Medical DevicesRedwood City, US
Alex DiNello(Executive Officer, Director)
BoardRichard Mott(Director)Justin Klein(Director)inBrent Ahrens(Director)inJason Lettman(Director)John Ryan(Director)
Co-investorsCanaan PartnersLightstone VenturesNew Enterprise Associates (NEA)MorgenthalerVensana Capital
HealthtechSan Francisco, US
Reza Naima(Executive Officer, Director)
Co-investorsLaunchCapitalEmergent Medical PartnersLaunch CapitalNorwich Ventures
HealthtechSan Jose, US
Duncan Maitland(Director)inMichael Henson(Executive Officer, Director)inEdward F. Ruppel, Jr(Executive Officer, Director)Carolyn M. Bruguera(Executive Officer)James Y Lancaster(Executive Officer, Director)in
BoardThom Rasche(Director)
Co-investorsEarlybird Venture CapitalTaiwania Capital
Standard Bariatrics develops the Titan SGS™ Stapler, a specialized surgical device designed for sleeve gastrectomy procedures that creates consistent and symmetrical gastric pouches using an anatomy-based approach.
Medical Devices
Co-investorsCincyTechHatteras Venture PartnersJobsOhio VenturesRC CapitalRiverVest Venture PartnersUS Venture Partners
BiotechHealthtechPompano Beach, US
Laura Tyler Perryman(Director)Regina Groves(Executive Officer, Director)Virginia Sullivan(Executive Officer)Marc Loev(Director)Richard Chen Mao(Director)Gary Perryman(Director)
Co-investorsSV Health Investors
Suture Ease develops and commercializes proprietary devices for laparoscopic surgery, with a flagship CrossBow Fascial Closure System that uses a "snare guide" technology and suture passer for trocar site closure.
Medical DevicesSan Jose, US
Scott Heneveld(Founder & COO)Kirt Kirtland(CEO)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ArdianCrux BiomedicalCyberHeartEvalveIncline TherapeuticsNanostimNovareOrlucentReverse MedicalSinuSysSonoma OrthopedicsSP SurgicalTransAortic MedicalTwelveVivaRay
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 12
3 IPOs · 9 acquisitions · showing 11EBR SystemsOTC: EBRCZFractylNASDAQ: GUTSHeartFlowNASDAQ: HTFLBioTrace Medicalacq. by Merit MedicalCyberHeartacq. by VarianEvalveacq. by Abbott VascularFocal Therapeuticsacq. by HologicIncline Therapeuticsacq. by The Medicines CompanyNanostimacq. by St. Jude MedicalTwelveacq. by MedtronicVivaRayacq. by Varian Medical Systems
Portfolio news
latest coverage across their companies
Shape Memory Medical · gsmedtech.com · Aug 27, 2026
HeartFlow · seekingalpha.com · Aug 16, 2026
Fractyl · investing.com · Jul 15, 2026
Frequently asked questions
- How many investments has Emergent Medical Partners, LLP made?
- Emergent Medical Partners, LLP has 36 tracked investments, 12 of which have exited.
- What stage does Emergent Medical Partners, LLP invest at?
- Emergent Medical Partners, LLP invests at the Seed, Series A stages.
- What sectors does Emergent Medical Partners, LLP focus on?
- Emergent Medical Partners, LLP focuses on Biotech, Healthtech, Medical Devices.
- Where is Emergent Medical Partners, LLP located?
- Emergent Medical Partners, LLP is headquartered in San Jose, US.
- Who does Emergent Medical Partners, LLP co-invest with?
- Emergent Medical Partners, LLP most often shares deals with Khosla Ventures, New Enterprise Associates (NEA), US Venture Partners, among 28 tracked co-investors.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.